Question: Is it possible to use antiretrovirals to treat COVID-19

Answer passage (source: WHO):
page_title: Q&A: HIV, antiretrovirals and COVID-19
section_headers: What is WHO’s position on the use of antiretrovirals for the treatment of COVID-19?
section_content: Currently, there is insufficient data to assess the effectiveness of LPV/r or
other antivirals for treating COVID-19. Several countries are evaluating the
use of LPV/r and other antivirals and we welcome the results of these
investigations.
Again, as part of WHO’s response to the outbreak, the
WHO R&D Blueprint
has been activated to accelerate evaluation of diagnostics,
vaccines and therapeutics for this novel coronavirus. WHO has also designed a
set of procedures to assess the performance, quality and safety of medical
technologies during emergency situations.

Reviewer feedback on this answer:
It admits that there is not enough data is give a good answer. It explains why the data isn't here yet.
Says that information isn't available yet but research about antiretroviral efficacy is ongoing.

Reviewer ratings:
Excellent
Excellent

Answer passage (source: WHO):
page_title: Q&A: HIV, antiretrovirals and COVID-19
section_headers: What studies on treatment and prevention of COVID-19 with antiretrovirals are being planned?
section_content: Several randomized trials are planned to assess the safety and efficacy of
using antiretroviral drugs – mainly LPV/r – for treating COVID-19, in
combination with other drugs. Results are expected from mid-2020 onwards.  

Reviewer feedback on this answer:
Says that research assessing the efficacy of antiretrovirals is ongoing and results are expected in mid 2020.
The answer is relevant. It admits that the data on it aren't here yet.

Reviewer ratings:
Excellent
Excellent

Answer passage (source: WHO):
page_title: Q&A: HIV, antiretrovirals and COVID-19
section_headers: Can antiretrovirals be used to treat COVID-19?
section_content: Several studies have suggested that patients infected with the virus causing
COVID-19, and the related coronavirus infections (SARS-CoV and MERS-CoV) had
good clinical outcomes, with almost all cases recovering fully. In some cases,
patients were given an antiretroviral drug: lopinavir boosted with ritonavir
(LPV/r). These studies were mostly carried out in HIV-negative individuals.
It is important to note that these studies using LPV/r had important
limitations. The studies were small, timing, duration and dosing for treatment
were varied and most patients received co-interventions/co-treatments which
may have contributed to the reported outcomes.
While the evidence of benefit of using antiretrovirals to treat coronavirus
infections is of very low certainty, serious side effects were rare. Among
people living with HIV, the routine use of LPV/r as treatment for HIV is
associated with several side effects of moderate severity. However, as the
duration of treatment in patients with coronavirus infections was generally
limited to a few weeks, these occurrences can be expected to be low or less
than that reported from routine use.

Reviewer feedback on this answer:
Discusses several studies that used antiretrovirals as a treatment for COVID-19.
It talks about what studies have been done to test the drugs. It only talks about one drug.

Reviewer ratings:
Excellent
Acceptable